Search
Please choose your country
more info

Contact:
Phone:+49 0761 1514 440 Fax:+49 0761 1514 460 Email: info@falkfoundation.org

Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

Falk Gastro Review Journal

This page provides access to all FGR publications selected from international medical journals since mid-2022. You may browse the 1000+ articles by using one of the organ- or indication-related filters below or select all articles from a specific issue. If you are looking for ta specific journal edition, please have a look at the FGR print version. 

Esophagus to Small Intestine

Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: A multicenter, open-label, randomized controlled trial

Lancet Gastroenterol Hepatol. 2023;8(3):228–41

Liou JM, Jiang XT, Chen CC, Luo JC, Bair MJ, Chen PY, Chou CK, Fang YJ, Chen MJ, Chen CC, Lee JY, Yang TH, Yu CC, Kuo CC, Chiu MC, Chen CY, Shun CT, Hu WH, Tsai MH, Hsu YC, Tseng CH, Chang CY, Lin JT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium

Esophagus to Small Intestine

Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe

Am J Gastroenterol. 2023;118(2):269–75

Mégraud F, Graham DY, Howden CW, Trevino E, Weissfeld A, Hunt B, Smith N, Leifke E, Chey WD

Esophagus to Small Intestine

Long-term outcomes of peroral endoscopic myotomy for achalasia: A systematic review and meta-analysis

Endoscopy. 2023;55(2):167–75

Vespa E, Pellegatta G, Chandrasekar VT, Spadaccini M, Patel H, Maselli R, Galtieri PA, Carlani E, Sharma P, Hassan C, Repici A

Esophagus to Small Intestine

Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: A randomized trial

Gastroenterology. 2023;164(1):61–71

Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, Spechler S

Esophagus to Small Intestine

Eosinophilic gastritis and enteritis are increased in families with eosinophilic esophagitis

Am J Gastroenterol. 2023;118(2):263–8

Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson KA

Esophagus to Small Intestine

Phase 2 trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis

Gut. 2023;72(2):256–63

Samadder NJ, Foster N, McMurray RP, Burke CA, Stoffel E, Kanth P, Das R, Cruz-Correa M, Vilar E, Mankaney G, Buttar N, Thirumurthi S, Turgeon DK, Sossenheimer M, Westover M, Richmond E, Umar A, Della’Zanna G, Rodriguez LM, Szabo E, Zahrieh D, Limburg PJ

Esophagus to Small Intestine

Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: A prospective 16-year longitudinal cohort study

Lancet Oncol. 2023;24(1):107–16

Lee CYC, Olivier A, Honing J, Lydon AM, Richardson S, O’Donovan M, Tischkowitz M, Fitzgerald RC, di Pietro M

Esophagus to Small Intestine

Prevalence and prognostic significance of vitamin C deficiency in patients with acute upper gastrointestinal bleeding: A prospective cohort study

Aliment Pharmacol Ther. 2023;57(3):313–22

Hui S, Lim A, Koh E, Abasszade J, Morgan A, Tan PY, Lemoh C, Robertson M

Esophagus to Small Intestine

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn’s disease on combination therapy (SPARE): A multicenter, open-label, randomized controlled trial

Lancet Gastroenterol Hepatol. 2023;8(3):215–27

Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D’Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group